SCD and chronic myelogenous leukemia, BCR-ABL1 positive: Interestingly, they showed that higher expression of SCD1 was associated with better overall survival and may antagonize the development of more aggressive tumors, which is quite different from other cancer types although another report on chronic myeloid leukemia has similar observations (70).